Tosca Melissa 4
4 · KIORA PHARMACEUTICALS INC · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2025-04-01+15,543→ 15,543 totalExercise: $2.93From: 2026-04-01Exp: 2035-04-01→ Common Stock (15,543 underlying) - Award
Common Stock
2025-04-01+7,772→ 21,371 total
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.